Top Markets
#1 ADO Protocol ADO Protocol +337.34%
#2 GoPlus Security GoPlus Security +56.76%
#3 The Black Bull The Black Bull +52.61%
#4 Nockchain Nockchain +49.55%
#5 Tutorial Tutorial +49.26%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +41.29%
#7 Starpower Starpower +35.24%
#8 GAIB AID GAIB AID +24.67%
#9 Fake World Assets Fake World Assets +16.40%
#10 Casper Network Casper Network +15.91%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Classifica tra le azioni #33962
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Prezzo delle azioni
$0.5813
Capitalizzazione di mercato
$6.50M
Variazione (1 giorno)
-23.07%
Variazione (1 anno)
-56.29%
Paese
US
Scambia Citius Pharmaceuticals, Inc. (CTXR)

Categoria

Healthcare
Storico del prezzo dell'azione per Citius Pharmaceuticals, Inc. (CTXR)
Prezzo di chiusura più alto: $0.69 il 2026-08-01

Prezzo di chiusura più basso: $374.99 il 2014-10-01
Storico del prezzo dell'azione di Citius Pharmaceuticals, Inc. dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $513.82 30.81%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $991.94 51.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE